|
MFSD8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.120200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.352160E-04 |
| Normal-vs-Stage2 |
5.459800E-02 |
| Normal-vs-Stage3 |
6.168400E-01 |
| Normal-vs-Stage4 |
3.369400E-01 |
| Stage1-vs-Stage2 |
8.446200E-01 |
| Stage1-vs-Stage3 |
2.206400E-04 |
| Stage1-vs-Stage4 |
3.73490000000753E-05 |
| Stage2-vs-Stage3 |
3.282400E-02 |
| Stage2-vs-Stage4 |
1.666070E-02 |
| Stage3-vs-Stage4 |
6.751800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.418200E-02 |
| Normal-vs-AfricanAmerican |
1.993840E-01 |
| Normal-vs-Asian |
2.545800E-02 |
| Caucasian-vs-AfricanAmerican |
8.849200E-01 |
| Caucasian-vs-Asian |
4.143600E-01 |
| AfricanAmerican-vs-Asian |
2.690400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.962400E-01 |
| Normal-vs-Female |
7.812000E-04 |
| Male-vs-Female |
4.775600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.002800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.625960E-02 |
| Normal-vs-Age(61-80Yrs) |
7.011600E-02 |
| Normal-vs-Age(81-100Yrs) |
2.625200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.988100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.943900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.299250E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.747600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.926600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.601400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.17939999997063E-06 |
| Normal-vs-Grade 2 |
4.30470000000183E-05 |
| Normal-vs-Grade 3 |
3.448600E-01 |
| Normal-vs-Grade 4 |
3.57170000000462E-05 |
| Grade 1-vs-Grade 2 |
2.317000E-01 |
| Grade 1-vs-Grade 3 |
7.834500E-04 |
| Grade 1-vs-Grade 4 |
4.47569981076867E-10 |
| Grade 2-vs-Grade 3 |
3.796500E-04 |
| Grade 2-vs-Grade 4 |
2.16493489801906E-14 |
| Grade 3-vs-Grade 4 |
3.98070000295903E-08 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.63100000172278E-09 |
| Normal-vs-ccB subtype |
1.154610E-01 |
| ccA subtype-vs-ccB subtype |
7.07212066686225E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.071570E-02 |
| Normal-vs-N1 |
9.190300E-02 |
| N0-vs-N1 |
4.713900E-02 |
|
|
